DAFNA Capital Management as of March 31, 2012
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 57 positions in its portfolio as reported in the March 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Novadaq Technologies | 10.3 | $6.6M | 1.0M | 6.55 | |
| Pharmacyclics | 9.0 | $5.8M | 208k | 27.76 | |
| Ariad Pharmaceuticals | 8.0 | $5.1M | 320k | 15.98 | |
| Dynavax Technologies Corporation | 7.0 | $4.4M | 884k | 5.03 | |
| Ym Biosciences | 6.2 | $3.9M | 2.1M | 1.86 | |
| Insulet Corporation (PODD) | 5.0 | $3.2M | 165k | 19.14 | |
| Insulet Corporation Cvt 3.75 0 convert | 4.9 | $3.2M | 3.0M | 1.05 | |
| Discovery Laboratories | 4.3 | $2.7M | 1.0M | 2.68 | |
| Rigel Pharmaceuticals (RIGL) | 3.1 | $2.0M | 248k | 8.05 | |
| TranS1 (TSON) | 3.0 | $1.9M | 516k | 3.67 | |
| Given Imaging | 2.6 | $1.6M | 87k | 18.73 | |
| Cardica | 2.1 | $1.4M | 635k | 2.14 | |
| ISIS Pharmaceuticals | 1.9 | $1.2M | 141k | 8.77 | |
| InfuSystem Holdings (INFU) | 1.8 | $1.2M | 605k | 1.94 | |
| Spectranetics Corporation | 1.8 | $1.2M | 112k | 10.40 | |
| Pozen | 1.7 | $1.1M | 180k | 6.00 | |
| Cardionet | 1.6 | $1.1M | 342k | 3.08 | |
| Mannkind Corp note 3.750%12/1 | 1.6 | $1.0M | 1.9M | 0.54 | |
| Theragenics Corporation | 1.6 | $1.0M | 555k | 1.84 | |
| Nuvasive Inc. conv | 1.4 | $860k | 1.0M | 0.86 | |
| Derma Sciences | 1.2 | $789k | 82k | 9.62 | |
| BioSpecifics Technologies | 1.2 | $764k | 48k | 15.82 | |
| Viking Systems | 1.1 | $731k | 3.7M | 0.20 | |
| Achillion Pharmaceuticals | 1.1 | $712k | 74k | 9.58 | |
| Johnson & Johnson (JNJ) | 1.0 | $620k | 9.4k | 65.96 | |
| Transgenomic | 0.9 | $600k | 500k | 1.20 | |
| Rockwell Medical Technologies | 0.9 | $577k | 61k | 9.45 | |
| Exactech | 0.8 | $536k | 34k | 15.84 | |
| Gilead Sciences (GILD) | 0.8 | $520k | 11k | 48.83 | |
| Greatbatch | 0.8 | $516k | 21k | 24.52 | |
| Protalix BioTherapeutics | 0.8 | $478k | 75k | 6.37 | |
| Stereotaxis | 0.7 | $475k | 731k | 0.65 | |
| Edap Tms (EDAP) | 0.7 | $475k | 250k | 1.90 | |
| EnteroMedics | 0.7 | $456k | 202k | 2.26 | |
| Cutera (CUTR) | 0.7 | $446k | 52k | 8.55 | |
| Masimo Corporation (MASI) | 0.6 | $409k | 18k | 23.37 | |
| RTI Biologics | 0.6 | $386k | 104k | 3.70 | |
| Graymark Healthcare | 0.6 | $350k | 700k | 0.50 | |
| Vascular Solutions | 0.5 | $313k | 29k | 10.79 | |
| Digirad Corporation | 0.5 | $313k | 149k | 2.10 | |
| Conceptus | 0.4 | $277k | 19k | 14.37 | |
| Neuralstem | 0.4 | $276k | 247k | 1.12 | |
| Oncothyreon | 0.4 | $277k | 64k | 4.37 | |
| Cardiovascular Systems | 0.4 | $263k | 29k | 9.24 | |
| Sunshine Heart | 0.4 | $264k | 30k | 8.86 | |
| Biolinerx Ltd-spons | 0.4 | $251k | 87k | 2.87 | |
| Oncolytics Biotech | 0.3 | $215k | 51k | 4.23 | |
| Dex (DXCM) | 0.3 | $209k | 20k | 10.45 | |
| Medivation | 0.3 | $187k | 2.5k | 74.80 | |
| Trius Therapeutics | 0.3 | $178k | 33k | 5.36 | |
| CytRx Corporation | 0.2 | $151k | 377k | 0.40 | |
| Neurometrix | 0.2 | $147k | 199k | 0.74 | |
| Misonix | 0.2 | $130k | 64k | 2.02 | |
| Biodel | 0.1 | $62k | 105k | 0.59 | |
| Aspenbio Pharma | 0.0 | $14k | 19k | 0.73 | |
| Medlink International | 0.0 | $9.4k | 157k | 0.06 | |
| Combimatrix Corporation *w exp 05/01/201 | 0.0 | $3.0k | 23k | 0.13 |
